| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/01/2009 | WO2009085274A3 Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars |
| 10/01/2009 | WO2009060835A8 Novel ubiquilin-binding small molecule |
| 10/01/2009 | US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery |
| 10/01/2009 | US20090249500 System for monitoring bacterial tumor treatment |
| 10/01/2009 | US20090248316 Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugs |
| 10/01/2009 | US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems |
| 10/01/2009 | US20090247731 Boronic ester and acid compounds, synthesis and uses |
| 10/01/2009 | US20090247638 Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disorders |
| 10/01/2009 | US20090247620 Benzochromene Derivatives for Use in Liquid Crystal Media and as Therapeutic Active Substances |
| 10/01/2009 | US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 10/01/2009 | US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 10/01/2009 | US20090247592 Epothilones C, D, E, and F, Preparation and Compositions |
| 10/01/2009 | US20090247584 Phenoxy-piperidines for the treatment of diseases such as schizophrenia and depression |
| 10/01/2009 | US20090247528 Method of treating attention deficit disorder |
| 10/01/2009 | US20090247522 Hsp90 FAMILY PROTEIN INHIBITORS |
| 10/01/2009 | US20090247520 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-kappa B ACTIVATION |
| 10/01/2009 | US20090247486 Composition for oral substance coating, covering material for oral substance, edible container and oral substance using the same |
| 10/01/2009 | US20090247471 Inhibitors of cruzipain and other cysteine proteases |
| 10/01/2009 | US20090247460 Inhibitor of vascular endothelial cell growth factor |
| 10/01/2009 | US20090247450 G-csf liquid formulation |
| 10/01/2009 | US20090246259 Biocompatible material having biocompatible non-woven nano- or micro-fiber fabric produced by electrospinning method, and method for production of the material |
| 10/01/2009 | US20090246245 Subcutaneous implants releasing an active principle over an extended period of time |
| 10/01/2009 | US20090246232 Pharmaceutical composition |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246172 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 10/01/2009 | US20090246147 Delivery Of Antipsychotics Through An Inhalation Route |
| 10/01/2009 | CA2719605A1 Transdermally absorbable preparation |
| 10/01/2009 | CA2719601A1 A composition for stabilizing .beta.-blocker and transdermally absorbable preparation comprising the same |
| 10/01/2009 | CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 10/01/2009 | CA2719226A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 10/01/2009 | CA2719202A1 Anti-tumor agent comprising cytidine derivative and carboplatin |
| 10/01/2009 | CA2718727A1 Heterocyclic compound |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105143A1 Pharmaceutical compositions based on salts of tiotropium and ciclesonide |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105133A1 Intragastric floating-type levodopa sustained-release preparation |
| 09/30/2009 | EP2104503A1 Morpholine dopamine agonists for the treatment of pain |
| 09/30/2009 | EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 09/30/2009 | EP1555028B1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 09/30/2009 | EP1471892B1 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1349549B1 Novel medicament compositions based on salts of tiotropium and on ciclesonide |
| 09/30/2009 | EP1296701B1 Use of grifola frondosa fungus extracts |
| 09/30/2009 | EP1295604B1 Preventives and remedies for diseases in association with demyelination |
| 09/30/2009 | EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 09/30/2009 | EP1037649B1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/30/2009 | EP0983076B1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
| 09/30/2009 | CN101544599A Crystal of 1,2-dihydropyridine compound |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595334 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595299 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/29/2009 | US7595064 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 09/29/2009 | CA2484460C Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-yl]-1-piperidinyl]ethyl]-.alpha..alpha. dimethyl-benzeneacetic acid |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2464042C Mptp affinity labels |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2438891C Method for preparing optically active dihydropyrones |
| 09/29/2009 | CA2390295C A method for chemoprevention of prostate cancer |
| 09/29/2009 | CA2383983C Substituted indolealkanoic acids |
| 09/29/2009 | CA2379560C Purine derivatives inhibitors of tyrosine protein kinase syk |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2348391C Chromenone and chromanone derivatives as integrin inhibitors |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2328280C Thienopyrimidines |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
| 09/29/2009 | CA2311922C Thienopyrimidines |
| 09/29/2009 | CA2310661C Ep2-receptor agonists as neuroprotective agents for the eye |
| 09/29/2009 | CA2299361C Use of consensus interferon in combination with il-1 receptor antagonist for treatment of patients afflicted with multiple sclerosis |
| 09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
| 09/29/2009 | CA2293433C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 09/29/2009 | CA2289531C Composition and methods for treating alzheimer's disease and other amyloidoses |
| 09/29/2009 | CA2273852C Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 09/29/2009 | CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009117095A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/24/2009 | WO2009085270A3 Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
| 09/24/2009 | WO2009048532A3 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 09/24/2009 | US20090240337 Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone |
| 09/24/2009 | US20090239938 Preventive/remedy for arteriosclerosis |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239879 N-oxides of n-phenyl-2-pyrimidine-amine derivatives |
| 09/24/2009 | US20090239878 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents |
| 09/24/2009 | US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one |
| 09/24/2009 | US20090239842 Solutions containing epinastin |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239837 Cholesterol-producing yeast strains and uses thereof |
| 09/24/2009 | US20090239803 Bite-size carbohydrate nutritional products and methods for using same |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239240 Mutant Forms of Fas Ligand and Uses Thereof |